Mane E, Cursano G, Venetis K, Frascarelli C, Pepe F, Nacchio M, Palumbo L, Pisapia P, De Camilli E, Castellano I, Cerbelli B, Costarelli L, d’Amati G, Rizzo A, Santinelli A, Scatena C, Criscitiello C, De Angelis C, Dieci MV, Troncone G, Curigliano G, Viale G, Guerini-Rocco E, Malapelle U, Fusco N. PIK3CA testing in HR+/HER2− metastatic breast cancer: assessing pathology laboratories capacity and needs. Pathologica [Internet]. 2026 Feb. 6 [cited 2026 Feb. 7];117(6). Available from: https://www.pathologica.it/article/view/1603